1. An HIV Post-Exposure ProphylaxisPilot ProgramImplemented in Public Health Settings in Los Angeles Jennifer N Sayles, MD, MPH, Gary P García, MPH, Rosemary C Veniegas,…

Slide 1Adherence in TLC+: The Sticky Wicket Michael S. Saag, MD Center for AIDS Research University of Alabama at Birmingham USA Slide 2 One Mans Journey to Adherence: Michael…

Slide 1Midwife-led units in community settings Cape Peninsula, South Africa Associate Professor Sheila Clow Mr Jason Marcus & Mrs Carol Adams University of Cape Town…

1. ENSURING LINKAGE TO CARE FORRECENTLY RELEASED HIV POSITIVE INMATES2012 Texas HIV/STD ConferenceAustin, TX October 31, 2012 2. WHY ARE YOU HERE?• What Are You Expecting…

1. TEST AND TREATGardner Cascade in context 2. Intro to „Test and Treat‟ Most people in HIV treatment (ART) reachundetectable VL…

Slide 1 LINCS : Using Harm Reduction while working together with HIV+ patients in San Francisco Department of Public Health November 17, 2012 Harm Reduction Coalition National…

Slide 1 1 HIV/AIDS Human Immunodeficiency Virus Acquired Immunodeficiency Syndrome Slide 2 2 AIDS is Caused by HIV Is the one common denominator within a range of populations.…

Slide 1 TB Elimination in California Can We Get There? Navigating the Landmines CTCA April 28, 2011 Jennifer Flood MD MPH Chief, Tuberculosis Control Branch California Department…

Slide 1 The cost-effectiveness of interventions to prevent mother-to-child HIV transmission when mothers do not require treatment for their own health: Case study of Malawi…

Slide 1 HIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibits Subnanomolar Binding to Drug Resistant Variants Altman et al. JACS 2008, 130 6099-6113…